Published in J Immunol Methods on December 15, 1995
A tubular EHD1-containing compartment involved in the recycling of major histocompatibility complex class I molecules to the plasma membrane. EMBO J (2002) 3.35
Convergent synthesis of neoglycopeptides by coupling of 2-bromoethyl glycosides to cysteine and homocysteine residues in T cell stimulating peptides. Glycoconj J (1998) 0.75
Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med (1972) 24.43
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01
A new clinical scale for the staging of dementia. Br J Psychiatry (1982) 21.77
High efficiency polyoma DNA transfection of chloroquine treated cells. Nucleic Acids Res (1983) 9.94
Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol (2001) 8.88
Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci U S A (1974) 5.13
Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes. J Exp Med (1973) 5.03
RELATION OF A beta(1)-GLYCOPROTEIN OF HUMAN SERUM TO THE COMPLEMENT SYSTEM. J Exp Med (1960) 4.66
Bovine papilloma virus contains an activator of gene expression at the distal end of the early transcription unit. Mol Cell Biol (1983) 4.56
Replication of polyoma DNA in isolated nuclei. I. Characterization of the system from mouse fibroblast 3T6 cells. J Mol Biol (1972) 4.47
RNA-linked short DNA fragments during polyoma replication. Proc Natl Acad Sci U S A (1973) 4.42
Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma. Lancet (1972) 4.36
Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc Natl Acad Sci U S A (1975) 4.21
Clinical Dementia Rating (CDR). Psychopharmacol Bull (1988) 3.47
Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology (1996) 3.29
Non-contiguous segments of the polyoma genome required in cis for DNA replication. J Mol Biol (1982) 3.03
Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations. Int J Cancer (1975) 2.81
Identification of an active disaccharide unit of a glycoconjugate receptor for pneumococci attaching to human pharyngeal epithelial cells. J Exp Med (1983) 2.80
Cellular signalling in programmed cell death (apoptosis). Immunol Today (1990) 2.64
Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature (1977) 2.58
Repression of bovine papilloma virus replication is mediated by a virally encoded trans-acting factor. Cell (1986) 2.58
Hydroxyurea-induced accumulation of short fragments during polyoma DNA replication. I. Characterization of fragments. J Virol (1973) 2.57
Human lymphocyte subpopulations: classification according to surface markers and-or functional characteristics. Transplant Rev (1973) 2.53
Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology (1991) 2.53
Reliability of the Washington University Clinical Dementia Rating. Arch Neurol (1988) 2.48
Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neurol (1988) 2.38
The PapG adhesin of uropathogenic Escherichia coli contains separate regions for receptor binding and for the incorporation into the pilus. Proc Natl Acad Sci U S A (1989) 2.36
Construction and analysis of viable deletion mutants of polyoma virus. J Virol (1979) 2.30
Structural basis of pilus subunit recognition by the PapD chaperone. Science (1993) 2.30
Hydroxyurea-induced accumulation of short fragments during polyoma DNA replication. II. Behavior during incubation of isolated nuclei. J Virol (1973) 2.27
A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Arch Neurol (1998) 2.22
Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells. Scand J Immunol (1976) 2.18
Malakoplakia: evidence for monocyte lysosomal abnormality correctable by cholinergic agonist in vitro and in vivo. N Engl J Med (1977) 2.16
Surface markers on human B and T lymphocytes. IV. Distribution of surface markers on resting and blast-transformed lymphocytes. Scand J Immunol (1974) 2.16
Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems. J Exp Med (1976) 2.11
Replication of polyoma DNA in isolated nuclei. II. Evidence for semi-conservative replication. J Mol Biol (1972) 2.10
Evidence-based recommendations for the use of Negative Pressure Wound Therapy in traumatic wounds and reconstructive surgery: steps towards an international consensus. Injury (2011) 2.07
Heart-synchronized ventilation during general anesthesia for extracorporeal shock wave lithotripsy. Anesth Analg (1988) 2.01
Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex. J Immunol (1989) 1.98
Identification of binding sites on the regulatory A subunit of protein phosphatase 2A for the catalytic C subunit and for tumor antigens of simian virus 40 and polyomavirus. Mol Cell Biol (1992) 1.83
Sealing of gaps in duplex DNA by T4 DNA ligase. Nucleic Acids Res (1982) 1.81
EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients. Int J Cancer (1976) 1.81
Structural basis of the interaction of the pyelonephritic E. coli adhesin to its human kidney receptor. Cell (2001) 1.79
Monitoring of polychlorinated biphenyls in human blood plasma: methodological developments and influence of age, lactation, and fish consumption. Arch Environ Contam Toxicol (1997) 1.75
Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies. J Exp Med (1982) 1.74
Interlaboratory histopathologic assessment of Alzheimer neuropathology: different methodologies yield comparable diagnostic results. Alzheimer Dis Assoc Disord (1993) 1.72
Recycling and target binding capacity of human natural killer cells. J Exp Med (1981) 1.71
The role of proximity in the use of hospital emergency departments. Sociol Health Illn (1980) 1.67
Steroid diabetes--a sign of overtreatment with steroids in the renal graft recipient? Scand J Urol Nephrol Suppl (1980) 1.63
Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages. J Immunol (1987) 1.61
Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation. Infect Immun (1976) 1.61
Two cases of cauda equina syndrome following spinal-epidural anesthesia. Reg Anesth (1997) 1.60
Surface markers on human B and T-lymphocytes. IX. Two-color immunofluorescence studies on the association between ebv receptors and complement receptors on the surface of lymphoid cell lines. Int J Cancer (1976) 1.58
Characterization of polyoma mutants with altered middle and large T-antigens. J Virol (1981) 1.58
Factors associated with residents' attitudes toward dying patients. Fam Med (1999) 1.56
Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers. J Infect Dis (1990) 1.54
Hereditary papillary renal cell carcinoma: clinical studies in 10 families. J Urol (1995) 1.53
Obesity and complications in breast reduction surgery: are restrictions justified? J Plast Reconstr Aesthet Surg (2007) 1.51
Lactose repressor-operator DNA interactions: kinetic analysis by a surface plasmon resonance biosensor. Anal Biochem (1993) 1.50
Ethidium-bromide-inhibited restriction endonucleases cleave one strand of circular DNA. Gene (1982) 1.49
In vivo measurements of bone lead--a comparison of two x-ray fluorescence techniques used at three different bone sites. Phys Med Biol (1989) 1.46
Somatostatin release, electrical activity, membrane currents and exocytosis in human pancreatic delta cells. Diabetologia (2009) 1.46
Interleukin-10 mRNA expression in B-cell chronic lymphocytic leukaemia inversely correlates with progression of disease. Br J Haematol (1996) 1.45
Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines. Int J Cancer (1976) 1.41
Visual disturbances after industrial triethylamine exposure. Int Arch Occup Environ Health (1986) 1.41
Periplasmic chaperone recognition motif of subunits mediates quaternary interactions in the pilus. EMBO J (1998) 1.40
T-antigen expression by polyoma mutants with modified RNA splicing. EMBO J (1983) 1.39
Signal amplification using "spot-on-a-chip" technology for the identification of proteins via MALDI-TOF MS. Anal Chem (2001) 1.39
Magic Lite Chlamydia immunoassay in urogenital samples and urine versus chlamydial culture. Int J STD AIDS (1994) 1.39
Technology assessment revisited: does positron emission tomography have proven clinical efficacy? Neurology (1991) 1.39
Molecular cloning, expression, and characterization of amorpha-4,11-diene synthase, a key enzyme of artemisinin biosynthesis in Artemisia annua L. Arch Biochem Biophys (2000) 1.37
Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J Immunol (1990) 1.36
Reversible renal failure during treatment with captopril. Br Med J (1979) 1.35
Sensitization of human lymphocytes against autologous or allogeneic lymphoblastoid cell lines: characteristics of the reactive cells. Scand J Immunol (1974) 1.35
The activity and signaling range of mature BMP-4 is regulated by sequential cleavage at two sites within the prodomain of the precursor. Genes Dev (2001) 1.33
Evidence-based recommendations for negative pressure wound therapy: treatment variables (pressure levels, wound filler and contact layer)--steps towards an international consensus. J Plast Reconstr Aesthet Surg (2011) 1.33
Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes. Clin Exp Immunol (1975) 1.31
Human spontaneous killer cells selective for tumour-derived target cells. Nature (1978) 1.30
Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine (1994) 1.30
Deletion mapping of a short polyoma virus middle T antigen segment important for transformation. J Virol (1983) 1.29
In vitro studies of lymphocytes from patients with plasma cell myeloma. II. Characterization by cell surface markers. Clin Exp Immunol (1973) 1.26
Synthesis of polyoma DNA by isolated nuclei. Biochem Biophys Res Commun (1971) 1.26
Polyunsaturated free fatty acids stimulate an increase in cytosolic Ca2+ by mobilizing the inositol 1,4,5-trisphosphate-sensitive Ca2+ pool in T cells through a mechanism independent of phosphoinositide turnover. J Biol Chem (1990) 1.26
The bovine papillomavirus replicon. Ciba Found Symp (1986) 1.22
Serine protein kinase activity associated with rotavirus phosphoprotein NSP5. J Virol (1997) 1.22
Drainage of thoracic duct lymph in renal transplant patients. Transplantation (1976) 1.21
Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus. Proc Natl Acad Sci U S A (1995) 1.21
Design and evaluation of pilicides: potential novel antibacterial agents directed against uropathogenic Escherichia coli. Chembiochem (2001) 1.20
Nucleosome structural features and intrinsic properties of the TATAAACGCC repeat sequence. J Biol Chem (1999) 1.20
In vitro induction of cytotoxic effector cells with spontaneous killer cell specificity. J Exp Med (1978) 1.19
Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain (2000) 1.19
Glycopeptides bind MHC molecules and elicit specific T cell responses. J Immunol (1993) 1.18
A molecular analysis of hyalin--a substrate for cell adhesion in the hyaline layer of the sea urchin embryo. Dev Biol (1998) 1.18
Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT). Bone Marrow Transplant (2012) 1.17
Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. J Biol Chem (1989) 1.17
Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations. Bone Marrow Transplant (2010) 1.16